Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the five research firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month target price among […]
More Stories
BlackBerry (TSE:BB) Trading 14.6% Higher – What’s Next?
BlackBerry Limited (TSE:BB – Get Free Report) (NASDAQ:BBRY)’s share price traded up 14.6% during mid-day trading on Monday . The...
Volt Information Sciences (NYSEAMERICAN:VOLT) Reaches New 52-Week Low – Should You Sell?
Volt Information Sciences, Inc. (NYSEAMERICAN:VOLT – Get Free Report) hit a new 52-week low on Monday . The stock traded...
N2OFF, Inc. (NASDAQ:NITO) Short Interest Update
N2OFF, Inc. (NASDAQ:NITO – Get Free Report) was the recipient of a significant increase in short interest in the month...
Croda International (LON:CRDA) Sets New 12-Month Low – Time to Sell?
Croda International Plc (LON:CRDA – Get Free Report) reached a new 52-week low on Monday . The company traded as...
JMP Securities Reiterates “Market Perform” Rating for Vacasa (NASDAQ:VCSA)
Vacasa (NASDAQ:VCSA – Get Free Report)‘s stock had its “market perform” rating reaffirmed by equities researchers at JMP Securities in...
Broadcom (NASDAQ:AVGO) Sees Large Volume Increase Following Analyst Upgrade
Shares of Broadcom Inc. (NASDAQ:AVGO – Get Free Report) saw unusually-strong trading volume on Monday after Barclays raised their price...